Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission ...

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...

Leveraged loans posted a modest, coupon-driven gain the past three months, but this was good enough to outperform both ...

In November 2024, GAM completed its CHF 100 million fully underwritten ordinary capital increase by way of a rights issue to support the implementation of GAM's strategy and provide long-term ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal ...

PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM announces 2024 full year results Strong progress in implementing turnaround strategy. GAM continues ...

Good morning and welcome to the ClearSign Technologies Fourth Quarter and Full Year 2024 Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's ...

Maxim Kouxenko - Manager, Investor Relations M: +1(647) 888-6458 E: [email protected] W: Americas-gold.com Americas Gold and Silver Corporation (TSX: USA) (NYSE American: USAS) ("Americas" or the ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure ...

All of our Jasper hotels were fully open by the end of 2024. Net income attributable to Pursuit of $368.5 million increased $352.5 million from the 2023 full year primarily due to the sale of the ...

Q4 2024 Earnings Call Transcript April 1, 2025 Operator: All sites on hold. We do appreciate your patience in holding and ask ...

There will be plenty of trucks, cars and bikes on display, with show awards taking place across all three vehicle categories.